TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.

Joshua D Brody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.